标题
NSD2 is a conserved driver of metastatic prostate cancer progression
作者
关键词
-
出版物
Nature Communications
Volume 9, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-11-30
DOI
10.1038/s41467-018-07511-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The Evolutionary Landscape of Localized Prostate Cancers Drives Clinical Aggression
- (2018) Shadrielle Melijah G. Espiritu et al. CELL
- Structural Alterations Driving Castration-Resistant Prostate Cancer Revealed by Linked-Read Genome Sequencing
- (2018) Srinivas R. Viswanathan et al. CELL
- Characterization of H3.3K36M as a tool to study H3K36 methylation in cancer cells
- (2017) Saumya M. Sankaran et al. Epigenetics
- AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
- (2017) Ni Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Genomic hallmarks of localized, non-indolent prostate cancer
- (2017) Michael Fraser et al. NATURE
- Emerging Variants of Castration-Resistant Prostate Cancer
- (2017) Panagiotis J. Vlachostergios et al. Current Oncology Reports
- NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis
- (2017) Suraj Peri et al. Nature Communications
- BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer
- (2017) Shin-Heng Chiou et al. Cancer Discovery
- Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer
- (2017) Min Zou et al. Cancer Discovery
- An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis
- (2017) Logan A. Walsh et al. Cell Reports
- The Role of Nuclear Receptor–Binding SET Domain Family Histone Lysine Methyltransferases in Cancer
- (2017) Richard L. Bennett et al. Cold Spring Harbor Perspectives in Medicine
- Neuroendocrine Prostate Cancer: Subtypes, Biology, and Clinical Outcomes
- (2017) Rahul Aggarwal et al. Journal of the National Comprehensive Cancer Network
- Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs
- (2016) Gerard L. Brien et al. CANCER CELL
- A PWWP Domain of Histone-LysineN-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin
- (2016) Saumya M. Sankaran et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate cancer
- (2016) Gerhardt Attard et al. LANCET
- Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
- (2016) Akash Kumar et al. NATURE MEDICINE
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents
- (2016) M Y Shah et al. ONCOGENE
- NSD2 contributes to oncogenic RAS-driven transcription in lung cancer cells through long-range epigenetic activation
- (2016) Verónica García-Carpizo et al. Scientific Reports
- Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy
- (2016) Milan S. Geybels et al. Clinical Epigenetics
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Combined Tumor Suppressor Defects Characterize Clinically Defined Aggressive Variant Prostate Cancers
- (2015) A. M. Aparicio et al. CLINICAL CANCER RESEARCH
- The evolutionary history of lethal metastatic prostate cancer
- (2015) Gunes Gundem et al. NATURE
- Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue
- (2015) Colin S Cooper et al. NATURE GENETICS
- Pancreatic Cancer Metastases Harbor Evidence of Polyclonality
- (2015) R. Maddipati et al. Cancer Discovery
- Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation
- (2014) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Cross-Species Regulatory Network Analysis Identifies a Synergistic Interaction between FOXM1 and CENPF that Drives Prostate Cancer Malignancy
- (2014) Alvaro Aytes et al. CANCER CELL
- High-risk prostate cancer—classification and therapy
- (2014) Albert J. Chang et al. Nature Reviews Clinical Oncology
- Luminal Cells Are Favored as the Cell of Origin for Prostate Cancer
- (2014) Zhu A. Wang et al. Cell Reports
- Origins of Metastatic Traits
- (2013) Sakari Vanharanta et al. CANCER CELL
- Punctuated Evolution of Prostate Cancer Genomes
- (2013) Sylvan C. Baca et al. CELL
- Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia
- (2013) Jacob D Jaffe et al. NATURE GENETICS
- ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer
- (2013) A. Aytes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transcriptional control of cancer metastasis
- (2013) Brian Ell et al. TRENDS IN CELL BIOLOGY
- Cancer Epigenetics: From Mechanism to Therapy
- (2012) Mark A. Dawson et al. CELL
- Characterization of the EZH2-MMSET Histone Methyltransferase Regulatory Axis in Cancer
- (2012) Irfan A. Asangani et al. MOLECULAR CELL
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape
- (2012) Bradley N Bidwell et al. NATURE MEDICINE
- The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial–mesenchymal transition and invasive properties of prostate cancer
- (2012) T Ezponda et al. ONCOGENE
- Emerging Epigenetic Targets and Therapies in Cancer Medicine
- (2012) Relja Popovic et al. Cancer Discovery
- NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
- (2011) Alex J. Kuo et al. MOLECULAR CELL
- Suppression of lung adenocarcinoma progression by Nkx2-1
- (2011) Monte M. Winslow et al. NATURE
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Molecular sampling of prostate cancer: a dilemma for predicting disease progression
- (2010) Andrea Sboner et al. BMC Medical Genomics
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development
- (2010) T. Bianco-Miotto et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Modeling metastasis in the mouse
- (2010) Paula D Bos et al. CURRENT OPINION IN PHARMACOLOGY
- The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription
- (2009) Hee-Bum Kang et al. FEBS LETTERS
- A luminal epithelial stem cell that is a cell of origin for prostate cancer
- (2009) Xi Wang et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started